Finance

Beta
Lists
Q1 2027 earnings • in 4 days
See details
ROSSARI:NSE
Rossari Biotech Ltd
₹530.00
+0.28%
(+1.50) 1D
Jul 14, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ROSSARI...
Open
₹530.00
High
₹542.00
Low
₹523.15
Mkt. cap
29.36B
Avg. vol.
112.70K
Volume
99.84K
Dividend
0.09%
Quarterly dividend
₹0.13
Ex-dividend date
Jul 10, 2026
P/E ratio
19.68
52-wk high
₹766.00
52-wk low
₹375.00
EPS
₹26.93
No. of employees
585
Open
₹530.00
High
₹542.00
Low
₹523.15
Mkt. cap
29.36B
Avg. vol.
112.70K
Volume
99.84K
Dividend
0.09%
Quarterly dividend
₹0.13
Ex-dividend date
Jul 10, 2026
P/E ratio
19.68
52-wk high
₹766.00
52-wk low
₹375.00
EPS
₹26.93
No. of employees
585
News stories
From sources across the web
Profile
Rossari Biotech is an Indian chemical manufacturing company with a focus on specialty chemicals. It is also engaged in production of specialty enzymes and chemicals in India that is used in the pharmaceuticals, paper, construction, textiles, nutrition and animal health industries. The company was started in 2003 as a partnership firm titled Rossari Labtech and was incorporated into a company in 2009 and was renamed as Rossari Biotech. It has two R&D facilities, one at Silvassa manufacturing facility and the second in Dahej. Wikipedia
About Rossari Biotech Ltd
CEO-
Employees585
FoundedAug 10, 2009
Headquarters-
SectorSpeciality chemicals
Next call in 4 days
Sat, Jul 18, 8:38 AM
Fiscal period
Q1 2027
EPS / Est. (INR)
- / ₹8.80
Revenue / Est. (INR)
- / 6.71B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.44B
5.86B
5.82B
6.85B
Cost of goods sold
3.71B
4.01B
4.01B
5.04B
Cost of revenue
3.71B
4.01B
4.01B
5.04B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
374.65M
377.99M
402.56M
463.26M
Operating expense
1.22B
1.32B
1.32B
1.44B
Total operating expenses
4.94B
5.32B
5.32B
6.48B
Operating income
501.06M
536.91M
492.59M
369.04M
Other non operating income
12.00M
16.04M
5.09M
-27.71M
EBT including unusual items
460.99M
496.72M
425.01M
642.43M
EBT excluding unusual items
460.99M
496.72M
425.01M
437.87M
Income tax expense
125.03M
127.96M
97.27M
182.76M
Effective tax rate
27.12%
25.76%
22.89%
28.45%
Other operating expenses
670.48M
755.29M
717.50M
736.59M
Net income
335.96M
368.76M
327.74M
459.67M
Net profit margin
6.18%
6.29%
5.63%
6.71%
Earnings per share
6.06
6.65
5.91
8.29
Interest and investment income
-
-
-
13.51M
Interest expense
-57.28M
-60.91M
-76.65M
-90.59M
Net interest expenses
-57.28M
-60.91M
-76.65M
-77.08M
Depreciation and amortization charges
177.49M
182.33M
196.14M
235.28M
EBITDA
654.45M
716.82M
645.98M
544.80M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more